This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussion of VTAMA (tapinarof cream) with a KOL on plaque psoriasis

Ticker(s): ROIV

Who's the expert?

Institution: Mount Sinai

  • President of New York State Society of Dermatology and past chairman of the Psoriasis Task Force, and President of American Academy of Dermatology.
  • Author or Co-author of over 500 publications and very involved in clinical trials for new dermatologic treatments. Edited the first atlas devoted entirely to cutaneous manifestations of systemic disease, now in fifth edition.
  • Founder of Psoriasis Forum and medical editor of the bulletin of the National Psoriasis Foundation.

Interview Goal
Discussion of tapinarof with a KOL on plaque psoriasis

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.